. . . . . "Ketamine" . . . . . . "Ketamine has emerged as a rapid-acting antidepressant, though controversy remains whether sufficient data exist to justify its use outside of research protocols. In October 2014, the authors' institution began providing ketamine as an off-label therapy on a case-by-case basis for patients unable to participate in research protocols." . . . . . . . "adults" . . . "major depressive disorder" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "F995PDvR3m15zWr+CKOCcHsFuisuzRQN2zjsDAO/Vem/OmT+BVtUXNI76FC4Bh2lSiOPwao+i6/8mzHhtCc40WvivNHbYMAhCx5EhlSGB6uhdxwVDM5Oils7f2GfTGMrvtVsiXuGsJiv8mKYyCfdjBsl+rgea1Z+e4c9FYyVjvo=" . . "2022-09-16T11:53:51.268635"^^ . . . "2.3.0" .